Background Hemodynamic instability and myocardial dysfunction are major factors
preventing the transplantation of hearts from organ donors after brain death. Intravenous …

Organ transplantation is a life-saving intervention for patients suffering from end-stage organ
failure, but it relies on the availability of donor organs. However, even when donors are …

Introduction During brain death, several events occur, including hormonal. metabolic and
systemic changes. This systematic review aims to find the role of hormone therapy in …

Objectives To investigate whether recipient administration of thyroid hormone (liothyronine
[T3]) is associated with reduced rates of primary graft dysfunction (PGD) after orthotopic …

Background. Hormonal replacement therapy is administered to many brain-dead organ
donors to improve hemodynamic stability. Previous clinical studies present conflicting results …

Background: Orthotopic heart transplantation (HTx) is a long-term surgical therapeutic
approach for patients with end-stage heart failure. The objective of the present study was to …

Background Pituitary dysfunction after brainstem death can cause various hormone
deficiencies in potential heart donors. The aim of this study was to evaluate the relationship …

Introduction. The use of thyroid hormone supplementation (THS) for donor optimization has
not been standardized and remains an area of academic investigation and clinical interest …

肺移植是治疗多种终末期肺部疾病的唯一有效手段, 术后能够显著改善患者生活质量和提高生存
时间, 而供肺质量是影响围手术期并发症发生的关键因素, 边缘肺用于肺移植 …

2023 was a record-breaking year for organ donation and transplantation, including a record
for heart transplants in the United States (4,545). 1 The donor pool was notable for an …